Background Documentation Gastrointestinal • Colon and Rectum 4.0.1.0
27. Kirsch R, Messenger DE, Riddell RH, et al. Venous invasion in colorectal cancer: impact of an elastin stain
on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Am J
Surg Pathol. 2013;37(2):200-210.
28. Liebig C, Ayala G, Wilks J, et al. Perineural invasion is an independent predictor of outcome in colorectal
cancer. J Clin Oncol. 2009;27(31):5131-5137.
29. Ueno H, Shirouzu K, Eishi Y, et al; Study Group for Perineural Invasion projected by the Japanese Society
for Cancer of the Colon and Rectum (JSCCR). Characterization of perineural invasion as a component of
colorectal cancer staging. Am J Surg Pathol. 2013;37(10):1542-1549.
30. Gomez D, Zaitoun AM, De Rosa A, et al. Critical review of the prognostic significance of pathological
variables in patients undergoing resection for colorectal liver metastases. HPB (Oxford). 2014;16(9):836-844.
31. Peng SL, Thomas M, Ruszkiewicz A, Hunter A, Lawrence M, Moore J. Conventional adverse features do not
predict response to adjuvant chemotherapy in stage II colon cancer. ANZ J Surg. 2014;84(11):837-841.
32. Ozturk MA, Dane F, Karagoz S, et al. Is perineural invasion (PN) a determinant of disease free survival in
early stage colorectal cancer? Hepatogastroenterology. 2015;62(137):59-64.
33. Huh JW, Kim HR, Kim YJ. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Ann Surg Oncol. 2010;17(8):2066-2072.
34. Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal
carcinoma. Gastroenterology. 2004 ;127(2):385-394.
35. Choi DH, Sohn DK, Chang HJ, Lim SB, Choi HS, Jeong SY. Indications for subsequent surgery after
endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Dis Colon
Rectum. 2009;52(3):438-445.
36. Petrelli F, Pezzica E, Cabiddu M, et al. Tumour Budding and Survival in Stage II Colorectal Cancer: a
Systematic Review and Pooled Analysis. J Gastrointest Cancer. 2015;46(3):212-218.
37. Graham RP, Vierkant RA, Tillmans LS, et al. Tumor budding in colorectal carcinoma: confirmation of
prognostic significance and histologic cutoff in a population-based cohort. Am J Surg Pathol.
2015;39(10):1340-1346.
38. Koelzer VH, Zlobec I, Lugli A. Tumor budding in colorectal cancer-ready for diagnostic practice? Hum Pathol.
2016;47(1):4-19.
39. Lugli A, Kirsch R, Ajioka Y, Bosman F, et al. Recommendations for reporting tumor budding in colorectal
cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. In
press.
40. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from
an expert panel. Am J Gastroenterol. 2012;107(9):1315-1330.
41. Anwar MA, D'Souza F, Coulter R, Memon B, Khan IM, Memon MA. Outcome of acutely perforated colorectal
cancers: experience of a single district general hospital. Surg Oncol. 2006;15(2):91-96.
42. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal
cancer. Br J Surg. 1996;83(3):375-379.
43. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal
excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-646. [summary for patients in Med J
Aust. 2002 Nov 18;177(10):563-564; PMID: 12429007]
63. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal
cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261-268.
62. Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas.
Am J Surg Pathol. 2003;27(5):563-570.
44. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between
surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449-457.
45. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH; Pathology Review
Committee; Cooperative Clinical Investigators. Circumferential margin involvement is still an important
predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg
Pathol. 2002;26(3):350-357.
46. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to
preoperative radiation and chemotherapy. Ann Surg. 2002;236(1):75-81.
47. Gavioli M, Luppi G, Losi L, et al. Incidence and clinical impact of sterilized disease and minimal residual
disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum. 2005;48(10):1851-1857.
48. Ryan R, Gibbons D, Hyland JMP, et al. Pathological response following long-course neoadjuvant
chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141-146.
27